How Long to Stop GLP-1 Before Surgery: Anesthesia Guide
GLP-1 medications delay gastric emptying, creating real risks during anesthesia. Here are the current guidelines for safely pausing your medication before any surgical procedure.
Important Safety Information: Always inform your surgeon, anesthesiologist, and surgical team that you take a GLP-1 medication. Do not adjust or stop medication without consulting your prescribing provider. This article reflects ASA guidelines current as of 2026 but guidelines may change.
If you take semaglutide, tirzepatide, or any other GLP-1 receptor agonist and have an upcoming surgery, you need to plan ahead. These medications slow how quickly your stomach empties, which creates a specific and serious risk during anesthesia.
Why You Must Stop GLP-1 Before Surgery
GLP-1 medications work partly by slowing gastric emptying, which helps you feel full longer and reduces appetite. But during anesthesia, a full or partially full stomach creates a dangerous scenario:
- Pulmonary aspiration: Stomach contents can travel up the esophagus and into the lungs while you are sedated and your protective reflexes are suppressed
- Aspiration pneumonia: If stomach acid or food particles enter the lungs, they can cause severe chemical burns to lung tissue and infection
- Standard fasting may not be enough: The typical "nothing after midnight" fasting rule assumes normal gastric emptying. GLP-1 medications can leave food in your stomach much longer than expected, even after an overnight fast
Current ASA Guidelines (2026)
| Medication | Formulation | Minimum Stop Time |
|---|---|---|
| Semaglutide (Ozempic/Wegovy) | Weekly injection | 7 days before |
| Semaglutide (Rybelsus) | Daily oral | 24-48 hours (some say 7 days) |
| Tirzepatide (Mounjaro/Zepbound) | Weekly injection | 7 days before |
| Liraglutide (Saxenda/Victoza) | Daily injection | 24-48 hours before |
| Dulaglutide (Trulicity) | Weekly injection | 7 days before |
| Exenatide (Byetta) | Twice daily injection | 24 hours before |
| Exenatide ER (Bydureon) | Weekly injection | 7 days before |
Day of Surgery: What Happens
Even if you stopped GLP-1 on schedule, your anesthesiologist may take additional precautions:
- Gastric ultrasound: A quick bedside ultrasound to check whether your stomach is empty
- Extended fasting verification: Confirming when you last ate and drank
- Rapid sequence induction: A modified anesthesia technique that protects the airway more aggressively
- GI symptoms inquiry: Asking about nausea, vomiting, or bloating that might suggest retained gastric contents
Applies to All Procedures Under Sedation
These guidelines apply to any procedure involving anesthesia or deep sedation, including:
- Major surgery (joint replacement, hernia repair, bariatric surgery)
- Minor surgery (gallbladder removal, colonoscopy, endoscopy)
- Dental procedures under sedation
- Fertility procedures (egg retrieval)
- Cosmetic surgery
- Any procedure requiring intubation
Restarting GLP-1 After Surgery
Most patients can restart GLP-1 medication once they are:
- Eating and drinking normally
- No longer taking opioid pain medications (which also slow gastric emptying)
- Cleared by their surgeon, typically 1-4 weeks post-surgery
Your prescribing provider may recommend restarting at a lower dose and re-titrating, especially if you were off the medication for more than 2 weeks.
Frequently Asked Questions
How long before surgery should I stop semaglutide?
The American Society of Anesthesiologists recommends stopping weekly semaglutide injections at least 7 days before elective surgery. Some anesthesiologists prefer a longer pause of 2-3 weeks. Daily oral semaglutide should be stopped at least 24-48 hours before, though some providers recommend 7 days.
How long before surgery should I stop tirzepatide?
Tirzepatide is a weekly injection and should be stopped at least 7 days before elective surgery, consistent with ASA guidelines. Because tirzepatide's half-life is approximately 5 days, a 7-day pause allows significant but not complete clearance. Your anesthesiologist may request a longer washout.
What happens if I do not stop GLP-1 before surgery?
GLP-1 medications delay gastric emptying, meaning food may remain in your stomach longer than normal. During anesthesia, this increases the risk of pulmonary aspiration, where stomach contents enter the lungs. Aspiration can cause aspiration pneumonia, respiratory failure, or in severe cases, death. This is why the fasting guidelines are critical.
Will my surgery be cancelled if I forgot to stop GLP-1?
Potentially, yes. If your anesthesiologist learns you took GLP-1 medication within the recommended window, they may require a gastric ultrasound to check stomach contents, extend your fasting period, or postpone the procedure. Always inform your surgical team about all medications including GLP-1.
Can I still have emergency surgery while on GLP-1?
Yes. Emergency surgery proceeds regardless of GLP-1 status. Anesthesiologists use rapid sequence induction and other techniques to manage aspiration risk in emergencies. The guidelines about stopping GLP-1 apply to elective (planned) procedures where you have the option to prepare.
Need Help Planning Around Surgery?
Trimi clinicians can help coordinate your GLP-1 treatment around upcoming procedures, including pause and restart planning.
Get Started TodayMore on Pre-Surgery Weight Loss
GLP-1 Before Hernia Surgery
Weight loss timeline and preparation for hernia repair.
GLP-1 to Qualify for Hip Replacement
Meeting BMI requirements for joint replacement.
GLP-1 Before IVF: Meeting BMI Requirements
Timing GLP-1 washout for fertility treatment.
Managing GLP-1 Side Effects
Complete guide to managing GLP-1 side effects.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).